<!DOCTYPE html>
<html lang="en">
<head>
<script async src="https://www.googletagmanager.com/gtag/js?id=G-6H85DH0R8S"></script>
<script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments)}gtag('js',new Date());gtag('config','G-6H85DH0R8S');</script>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hypertension Medications: Types, How They Work, and Side Effects | hypertension.md</title>
    <meta name="description" content="A clear overview of the major classes of blood pressure medications — ACE inhibitors, ARBs, calcium channel blockers, diuretics, and beta-blockers. How they work, common side effects, and when each is used.">
    <link rel="canonical" href="https://hypertension.md/blog/hypertension-medication-types.html">
    <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 32 32'%3E%3Ctext x='16' y='24' font-family='-apple-system,system-ui,sans-serif' font-weight='800' font-size='16' fill='%230d9488' text-anchor='middle' letter-spacing='-0.5'%3E.md%3C/text%3E%3C/svg%3E">
    <link href="https://fonts.googleapis.com/css2?family=Source+Serif+4:wght@400;500;600;700&family=Inter:wght@400;500;600&display=swap" rel="stylesheet">
    <style>
        :root { --bg-primary: #ffffff; --bg-secondary: #f8fafc; --bg-tertiary: #f1f5f9; --text-primary: #0f172a; --text-secondary: #475569; --text-muted: #94a3b8; --accent: #0d9488; --accent-dark: #0f766e; --accent-light: #ccfbf1; --border: #e2e8f0; --font-display: 'Source Serif 4', Georgia, serif; --font-body: 'Inter', -apple-system, sans-serif; }
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: var(--font-body); background: var(--bg-primary); color: var(--text-primary); line-height: 1.7; font-size: 16px; }
        header { position: sticky; top: 0; z-index: 100; background: rgba(255,255,255,0.95); backdrop-filter: blur(10px); border-bottom: 1px solid var(--border); }
        .header-inner { max-width: 1100px; margin: 0 auto; padding: 16px 24px; display: flex; justify-content: space-between; align-items: center; }
        .logo { font-family: var(--font-display); font-size: 22px; font-weight: 600; color: var(--text-primary); text-decoration: none; }
        .logo span { color: var(--accent); }
        nav { display: flex; gap: 32px; }
        nav a { color: var(--text-secondary); text-decoration: none; font-size: 14px; font-weight: 500; transition: color 0.2s; }
        nav a:hover { color: var(--accent); }
        article { max-width: 720px; margin: 0 auto; padding: 80px 24px 64px; }
        .breadcrumb { font-size: 13px; color: var(--text-muted); margin-bottom: 32px; }
        .breadcrumb a { color: var(--accent); text-decoration: none; }
        h1 { font-family: var(--font-display); font-size: clamp(32px, 5vw, 42px); font-weight: 700; line-height: 1.2; margin-bottom: 16px; }
        .article-meta { font-size: 14px; color: var(--text-muted); margin-bottom: 40px; }
        .article-body h2 { font-family: var(--font-display); font-size: 26px; font-weight: 700; margin: 48px 0 16px; }
        .article-body h3 { font-family: var(--font-display); font-size: 20px; font-weight: 600; margin: 32px 0 12px; }
        .article-body p { font-size: 17px; color: var(--text-secondary); margin-bottom: 20px; }
        .article-body ul, .article-body ol { margin: 0 0 20px 24px; color: var(--text-secondary); }
        .article-body li { margin-bottom: 8px; font-size: 16px; }
        .article-body blockquote { border-left: 3px solid var(--accent); margin: 24px 0; padding: 16px 24px; background: var(--bg-secondary); border-radius: 0 8px 8px 0; }
        .article-body blockquote p { color: var(--text-secondary); margin-bottom: 0; }
        .article-body table { width: 100%; border-collapse: collapse; margin: 24px 0; font-size: 15px; }
        .article-body th, .article-body td { padding: 12px 16px; border: 1px solid var(--border); text-align: left; }
        .article-body th { background: var(--bg-secondary); font-weight: 600; }
        .sources { margin-top: 48px; padding-top: 32px; border-top: 1px solid var(--border); }
        .sources h3 { font-size: 16px; font-weight: 600; margin-bottom: 12px; }
        .sources ol { font-size: 14px; color: var(--text-muted); margin-left: 20px; }
        .sources li { margin-bottom: 6px; }
        .cta-box { background: var(--bg-secondary); border: 1px solid var(--border); border-radius: 12px; padding: 32px; text-align: center; margin-top: 48px; }
        .cta-box h3 { font-family: var(--font-display); font-size: 22px; margin-bottom: 8px; }
        .cta-box p { font-size: 15px; color: var(--text-secondary); margin-bottom: 16px; }
        .cta-button { display: inline-block; background: var(--accent); color: white; padding: 12px 24px; border-radius: 8px; font-weight: 600; font-size: 14px; text-decoration: none; transition: background 0.2s; }
        .cta-button:hover { background: var(--accent-dark); }
        footer { background: var(--bg-secondary); border-top: 1px solid var(--border); padding: 48px 24px; }
        .footer-inner { max-width: 1100px; margin: 0 auto; display: grid; grid-template-columns: 2fr 1fr 1fr 1fr; gap: 40px; }
        .footer-brand .logo { display: inline-block; margin-bottom: 12px; }
        .footer-brand p { font-size: 14px; color: var(--text-muted); line-height: 1.6; }
        .footer-links h4 { font-size: 12px; font-weight: 600; text-transform: uppercase; letter-spacing: 0.5px; margin-bottom: 12px; }
        .footer-links a { display: block; color: var(--text-muted); text-decoration: none; font-size: 14px; margin-bottom: 8px; transition: color 0.2s; }
        .footer-links a:hover { color: var(--accent); }
        .footer-bottom { max-width: 1100px; margin: 32px auto 0; padding-top: 24px; border-top: 1px solid var(--border); display: flex; justify-content: space-between; font-size: 13px; color: var(--text-muted); }
        @media (max-width: 768px) { nav { display: none; } h1 { font-size: 32px; } .footer-inner { grid-template-columns: 1fr; gap: 24px; } }
    </style>
</head>
<body>
    <header><div class="header-inner"><a href="/" class="logo">hypertension<span>.md</span></a><nav><a href="/">Home</a><a href="/blog/">Articles</a><a href="/resources.html">Resources</a><a href="/faq.html">FAQ</a></nav></div></header>

    <article>
        <div class="breadcrumb"><a href="/">Home</a> / <a href="/blog/">Articles</a> / Medication Types</div>
        <h1>Hypertension Medications: Types, How They Work, and What to Expect</h1>
        <div class="article-meta">February 9, 2026 &middot; 10 min read</div>

        <div class="article-body">
            <p>When lifestyle changes alone are not enough to bring blood pressure to target — or when the numbers are high enough that waiting poses risk — medication enters the picture. There are more than a dozen classes of antihypertensive drugs available, but five classes form the backbone of treatment. Each works through a different mechanism, and understanding those mechanisms helps explain why one drug may be chosen over another.</p>

            <p>This is not a guide for self-prescribing. It is an overview to help you understand the medication your doctor recommends, ask better questions, and know what to expect.</p>

            <h2>First-Line Medications</h2>

            <p>The 2017 ACC/AHA guidelines identify four classes as appropriate first-line therapy for most adults with hypertension: thiazide diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers. The choice among them depends on the patient's age, race, kidney function, comorbidities, and tolerance of side effects.</p>

            <h3>Thiazide Diuretics</h3>

            <p>Thiazide and thiazide-like diuretics (chlorthalidone, hydrochlorothiazide, indapamide) work by preventing sodium reabsorption in the kidneys. When less sodium is reabsorbed, more water is excreted, reducing blood volume and, consequently, blood pressure. Over the long term, they also reduce peripheral vascular resistance through mechanisms that are not entirely understood.</p>

            <p>Thiazides have been used since the 1950s and have the longest track record of any antihypertensive class. The ALLHAT trial, one of the largest hypertension studies ever conducted with over 33,000 participants, found that chlorthalidone was as effective as amlodipine (a calcium channel blocker) and lisinopril (an ACE inhibitor) at preventing major cardiovascular events, and superior for preventing heart failure.</p>

            <p><strong>Common side effects:</strong> Increased urination (usually resolves in a few weeks), low potassium, elevated uric acid, mild increases in blood glucose. Potassium levels should be monitored, particularly in patients also taking digoxin.</p>

            <h3>ACE Inhibitors</h3>

            <p>ACE inhibitors (lisinopril, enalapril, ramipril, benazepril) block the angiotensin-converting enzyme, which converts angiotensin I to angiotensin II — a potent vasoconstrictor. By reducing angiotensin II levels, these drugs relax blood vessels, lower aldosterone secretion (reducing sodium retention), and decrease the workload on the heart.</p>

            <p>ACE inhibitors are particularly well-suited for patients with diabetes, chronic kidney disease, or heart failure, because they slow the progression of kidney damage and reduce cardiac remodeling. The HOPE trial demonstrated that ramipril reduced the risk of myocardial infarction, stroke, and cardiovascular death by 22% in high-risk patients.</p>

            <p><strong>Common side effects:</strong> Dry cough (affects 5-20% of patients and is the most common reason for switching), elevated potassium, dizziness. Rarely, angioedema — swelling of the face, lips, or throat — which requires immediate discontinuation. ACE inhibitors are contraindicated in pregnancy.</p>

            <h3>Angiotensin Receptor Blockers (ARBs)</h3>

            <p>ARBs (losartan, valsartan, irbesartan, olmesartan) target the same hormonal pathway as ACE inhibitors but at a different point. Instead of blocking the enzyme that produces angiotensin II, they block the receptor where angiotensin II binds. The result is similar — vasodilation and reduced aldosterone — but without the cough that plagues many ACE inhibitor users, because ARBs do not increase bradykinin levels.</p>

            <p>ARBs are often prescribed when patients cannot tolerate ACE inhibitors. The LIFE trial showed that losartan was superior to atenolol (a beta-blocker) in reducing stroke risk among hypertensive patients with left ventricular hypertrophy.</p>

            <p><strong>Common side effects:</strong> Dizziness, elevated potassium, headache. Generally well tolerated. Like ACE inhibitors, ARBs are contraindicated in pregnancy. ACE inhibitors and ARBs should not be used together.</p>

            <h3>Calcium Channel Blockers</h3>

            <p>Calcium channel blockers (amlodipine, nifedipine, diltiazem, verapamil) reduce blood pressure by preventing calcium from entering the smooth muscle cells of blood vessel walls. Without calcium influx, the muscles relax and the vessels dilate. Dihydropyridines like amlodipine primarily affect blood vessels, while non-dihydropyridines like diltiazem and verapamil also slow the heart rate.</p>

            <p>Amlodipine is one of the most widely prescribed antihypertensives in the world. It has a long half-life, allowing once-daily dosing, and is effective across age groups and racial demographics. Clinical data suggest calcium channel blockers are particularly effective in Black patients and older adults, populations in which the renin-angiotensin system may play a less dominant role in blood pressure regulation.</p>

            <p><strong>Common side effects:</strong> Peripheral edema (swelling of the ankles and feet, especially with amlodipine), flushing, headache, constipation (particularly with verapamil). The ankle swelling is not a sign of heart failure — it results from local vasodilation — but it can be uncomfortable enough to warrant switching medications.</p>

            <h2>Second-Line and Add-On Medications</h2>

            <h3>Beta-Blockers</h3>

            <p>Beta-blockers (metoprolol, atenolol, carvedilol, propranolol) reduce blood pressure by slowing the heart rate and decreasing the force of contraction. They also reduce renin release from the kidneys. While they were once considered first-line therapy, several large trials and meta-analyses — including a Cochrane review — found them less effective than other classes at preventing stroke, particularly in older adults.</p>

            <p>The current guidelines position beta-blockers as add-on therapy or as preferred agents in specific situations: post-heart attack, heart failure with reduced ejection fraction, atrial fibrillation rate control, or patients with high sympathetic tone (rapid heart rate, anxiety-related blood pressure spikes).</p>

            <p><strong>Common side effects:</strong> Fatigue, cold hands and feet, weight gain, depression, erectile dysfunction, bradycardia. Beta-blockers should not be stopped abruptly, as this can cause rebound hypertension or tachycardia.</p>

            <h3>Aldosterone Antagonists</h3>

            <p>Spironolactone and eplerenone block aldosterone, a hormone that promotes sodium and water retention. These drugs are particularly useful in resistant hypertension — blood pressure that remains uncontrolled despite three or more medications. The PATHWAY-2 trial demonstrated that spironolactone was significantly more effective than bisoprolol or doxazosin as a fourth-line agent for resistant hypertension.</p>

            <p><strong>Common side effects:</strong> Elevated potassium (requires monitoring), gynecomastia and breast tenderness with spironolactone (less so with eplerenone), menstrual irregularities.</p>

            <h2>Combination Therapy</h2>

            <p>Most patients with Stage 2 hypertension will need two or more medications to reach their blood pressure target. The guidelines recommend starting with two drugs when blood pressure is 20/10 mmHg or more above goal. Certain combinations are preferred because they work through complementary mechanisms:</p>

            <ul>
                <li>ACE inhibitor or ARB + calcium channel blocker</li>
                <li>ACE inhibitor or ARB + thiazide diuretic</li>
                <li>Calcium channel blocker + thiazide diuretic</li>
            </ul>

            <p>Fixed-dose combination pills (two drugs in one tablet) improve adherence because they reduce the number of pills taken daily. A meta-analysis in The Lancet found that adherence to antihypertensive therapy drops by roughly 10% for each additional daily dose.</p>

            <h2>Choosing the Right Medication</h2>

            <table>
                <thead>
                    <tr><th>Condition</th><th>Preferred Class</th></tr>
                </thead>
                <tbody>
                    <tr><td>Diabetes with proteinuria</td><td>ACE inhibitor or ARB</td></tr>
                    <tr><td>Heart failure</td><td>ACE inhibitor/ARB + beta-blocker + diuretic</td></tr>
                    <tr><td>Post-myocardial infarction</td><td>Beta-blocker + ACE inhibitor</td></tr>
                    <tr><td>Chronic kidney disease</td><td>ACE inhibitor or ARB</td></tr>
                    <tr><td>Older adults / isolated systolic HTN</td><td>Thiazide or calcium channel blocker</td></tr>
                    <tr><td>Resistant hypertension</td><td>Add spironolactone</td></tr>
                </tbody>
            </table>

            <h2>Adherence: The Biggest Challenge</h2>

            <p>The World Health Organization estimates that only about 50% of patients with chronic conditions take their medications as prescribed. For hypertension, this is particularly problematic because the condition is usually asymptomatic. People feel fine, so they skip doses or stop altogether — and the consequences may not appear for years.</p>

            <p>If side effects are the reason for nonadherence, that is a solvable problem. There are enough medication options that most patients can find a regimen they tolerate well. The conversation with your doctor about side effects is not a complaint; it is clinically important information that guides treatment decisions.</p>

            <div class="sources">
                <h3>Sources</h3>
                <ol>
                    <li>Whelton PK, et al. 2017 ACC/AHA Guideline for High Blood Pressure in Adults. <em>Hypertension</em>. 2018;71(6):e13-e115.</li>
                    <li>ALLHAT Officers. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic. <em>JAMA</em>. 2002;288(23):2981-2997.</li>
                    <li>Yusuf S, et al. Effects of an ACE inhibitor, ramipril, on cardiovascular events in high-risk patients (HOPE). <em>N Engl J Med</em>. 2000;342(3):145-153.</li>
                    <li>Dahlof B, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction (LIFE) study. <em>Lancet</em>. 2002;359(9311):995-1003.</li>
                    <li>Williams B, et al. Spironolactone versus placebo, bisoprolol, and doxazosin for resistant hypertension (PATHWAY-2). <em>Lancet</em>. 2015;386(10008):2059-2068.</li>
                </ol>
            </div>

            <div class="cta-box">
                <h3>Understand your numbers first</h3>
                <p>Before adjusting medication, make sure you know what your blood pressure readings mean.</p>
                <a href="/blog/blood-pressure-basics.html" class="cta-button">Blood Pressure Basics</a>
            </div>
        </div>
    </article>

    <footer><div class="footer-inner"><div class="footer-brand"><a href="/" class="logo">hypertension<span>.md</span></a><p>Part of the <a href="https://thrive.md" style="color: var(--accent); text-decoration: none;">thrive.md</a> health network.</p></div><div class="footer-links"><h4>Resources</h4><a href="/resources.html">Resource Library</a><a href="/faq.html">Common Questions</a><a href="/blog/">Articles</a></div><div class="footer-links"><h4>About</h4><a href="https://thrive.md/editorial-policy.html">Editorial Policy</a><a href="https://thrive.md/medical-review.html">Medical Review</a><a href="mailto:hello@thrive.md">Contact</a></div><div class="footer-links"><h4>Network</h4><a href="https://thrive.md">thrive.md</a><a href="https://anxiety.md">anxiety.md</a><a href="https://adhd.md">adhd.md</a></div></div><div class="footer-bottom"><p>&copy; 2026 hypertension.md</p><p>Medical information, not medical advice</p></div></footer>
</body>
</html>